AQR Arbitrage’s SBC Medical Group Warrants SBCWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-53,431
Closed -$12.8K 447
2024
Q4
$12.8K Sell
53,431
-258,340
-83% -$62.3K ﹤0.01% 420
2024
Q3
$46.8K Sell
311,771
-53,503
-15% -$5.53K ﹤0.01% 387
2024
Q2
$25.9K Hold
365,274
﹤0.01% 417
2024
Q1
$12.8K Hold
365,274
﹤0.01% 464
2023
Q4
$10.3K Hold
365,274
﹤0.01% 507
2023
Q3
$21.9K Hold
365,274
﹤0.01% 527
2023
Q2
$21.7K Sell
365,274
-4,777
-1% -$224 ﹤0.01% 600
2023
Q1
$22.2K Sell
370,051
-4,949
-1% -$320 ﹤0.01% 724
2022
Q4
$20.7K Buy
+375,000
New +$17.4K ﹤0.01% 833

Other funds holding SBCWW

AQR Arbitrage's SBCWW Position: Q1 2025 in Review

AQR Arbitrage sold out of SBC Medical Group Warrants (SBCWW) in Q1 2025, closing a stake of 53,431 shares — an estimated $12.8K sold.

AQR Arbitrage first reported a position in SBCWW in Q4 2022 and held it in 9 quarters. The position peaked at $46.8K in Q3 2024. 21 funds tracked by Wall St. Rank hold SBCWW as of Q1 2025.

  • AQR Arbitrage reported no remaining SBC Medical Group Warrants position as of Q1 2025 after selling out during the quarter.
  • AQR Arbitrage sold 53,431 SBC Medical Group Warrants shares in Q1 2025, an estimated $12.8K.
  • AQR Arbitrage first reported a position in SBC Medical Group Warrants in Q4 2022 and held it in 9 quarters.
  • AQR Arbitrage's SBC Medical Group Warrants position peaked at $46.8K in Q3 2024.
  • 21 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q1 2025.

Based on AQR Arbitrage's 13F filing for Q1 2025, filed 15 May 2025.